This document summarizes the mechanisms of atopic dermatitis (AD). It discusses the epidemiology of AD and notes that it commonly affects children under 5 years old. The pathophysiology involves genetic, environmental, immunological, and epidermal factors. Key aspects of the pathophysiology discussed include the role of skin barrier dysfunction and genes involved in barrier function like filaggrin. It also examines the role of the immune system in AD, focusing on the predominance of TH2 cytokines and immune cells like dendritic cells, T lymphocytes, mast cells, and eosinophils that perpetuate the inflammatory response in AD.
hanifin and rajka criteria, entymology, definition of AD, atopy, etiopathogenesis of AD, genetics in AD, filaggrin, epidermal barrier dysfunction, atopic march, hygiene hypothesis, infantile phase of AD, childhood phase of AD, adult phase of AD, pityriasis alba, denne morgan folds, dirty neck appearence, nipple dermatitis, hanifin and rajka criteria, UK refinement of hanifin and rajka criteria, millenium criteria of AD, japanese dermatological association criteria, management of AD, wet wrap therapy,
Summary of updated information about the disease of Atopic dermatitis, aetiology, immunopathogenesis, main clinical features and dianostic criteria, concepts of managemnt of Atopic dermatitis including newest treatment trends.
hanifin and rajka criteria, entymology, definition of AD, atopy, etiopathogenesis of AD, genetics in AD, filaggrin, epidermal barrier dysfunction, atopic march, hygiene hypothesis, infantile phase of AD, childhood phase of AD, adult phase of AD, pityriasis alba, denne morgan folds, dirty neck appearence, nipple dermatitis, hanifin and rajka criteria, UK refinement of hanifin and rajka criteria, millenium criteria of AD, japanese dermatological association criteria, management of AD, wet wrap therapy,
Summary of updated information about the disease of Atopic dermatitis, aetiology, immunopathogenesis, main clinical features and dianostic criteria, concepts of managemnt of Atopic dermatitis including newest treatment trends.
Key Trends Shaping the Future of Infrastructure.pdfCheryl Hung
Keynote at DIGIT West Expo, Glasgow on 29 May 2024.
Cheryl Hung, ochery.com
Sr Director, Infrastructure Ecosystem, Arm.
The key trends across hardware, cloud and open-source; exploring how these areas are likely to mature and develop over the short and long-term, and then considering how organisations can position themselves to adapt and thrive.
Search and Society: Reimagining Information Access for Radical FuturesBhaskar Mitra
The field of Information retrieval (IR) is currently undergoing a transformative shift, at least partly due to the emerging applications of generative AI to information access. In this talk, we will deliberate on the sociotechnical implications of generative AI for information access. We will argue that there is both a critical necessity and an exciting opportunity for the IR community to re-center our research agendas on societal needs while dismantling the artificial separation between the work on fairness, accountability, transparency, and ethics in IR and the rest of IR research. Instead of adopting a reactionary strategy of trying to mitigate potential social harms from emerging technologies, the community should aim to proactively set the research agenda for the kinds of systems we should build inspired by diverse explicitly stated sociotechnical imaginaries. The sociotechnical imaginaries that underpin the design and development of information access technologies needs to be explicitly articulated, and we need to develop theories of change in context of these diverse perspectives. Our guiding future imaginaries must be informed by other academic fields, such as democratic theory and critical theory, and should be co-developed with social science scholars, legal scholars, civil rights and social justice activists, and artists, among others.
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualityInflectra
In this insightful webinar, Inflectra explores how artificial intelligence (AI) is transforming software development and testing. Discover how AI-powered tools are revolutionizing every stage of the software development lifecycle (SDLC), from design and prototyping to testing, deployment, and monitoring.
Learn about:
• The Future of Testing: How AI is shifting testing towards verification, analysis, and higher-level skills, while reducing repetitive tasks.
• Test Automation: How AI-powered test case generation, optimization, and self-healing tests are making testing more efficient and effective.
• Visual Testing: Explore the emerging capabilities of AI in visual testing and how it's set to revolutionize UI verification.
• Inflectra's AI Solutions: See demonstrations of Inflectra's cutting-edge AI tools like the ChatGPT plugin and Azure Open AI platform, designed to streamline your testing process.
Whether you're a developer, tester, or QA professional, this webinar will give you valuable insights into how AI is shaping the future of software delivery.
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
"Impact of front-end architecture on development cost", Viktor TurskyiFwdays
I have heard many times that architecture is not important for the front-end. Also, many times I have seen how developers implement features on the front-end just following the standard rules for a framework and think that this is enough to successfully launch the project, and then the project fails. How to prevent this and what approach to choose? I have launched dozens of complex projects and during the talk we will analyze which approaches have worked for me and which have not.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
2. Introduction
• AD is a chronic relapsing inflammatory skin disease
• More than 50% develop asthma
• 75% develop AR
• complex interrelationship of
▫ genetic, environmental, immunologic, and epidermal factors
Mark Boguniewicz, Donald Leung.Middleton’s Allergy 7’th edition 893-1999
3. Epidemiology
• Affects 15-30% of children, 2-10% of adult
• 45% begin within the first 6 mo
• 60% begin during the first yr
• 85% begin before 5 yrs
• Up to 70%: spontaneous remission
before adolescence
NJEM 2008;358:1483-94
NJEM 2008;358:1483-94
4. Acute AD
• Intensely pruritic, erythematous papule associated with
excoriations, vesiculation, and serous exudate
• Pathology : spongiosis (intercellular epidermal edema), superficial
epidermal hypertrophy and acantholysis
• marked infiltration of CD4 activated memory T cells, APCs, (LCs,
inflammatory dendritic epidermal cells (IDECs), macrophages),
and degranulated mast cell
Histology: Spongiotic area within the epidermis
5. Chronic AD
• thickened plaques with increased lichenification
• Pathology : marked epidermal hyperplasia, acanthosis
• macrophage-dominated mononuclear cell infiltrate in dermis, and
perivascular accumulation of lymphocytes in smaller numbers than
seen in acute AD
Hyperplastic of epidermis with hyperkeratosis
Adv Immunol.2009;102;135-226
6. Pathophysiology of AD
• Genetics
• Barrier function of the skin
• Immunopathologic mechanism
• Autoimmunity
NJEM 2008;358:1483-94
7. Genetics of AD
• atopic dermatitis–specific genes
• related loci on chromosomes 3q21,1q21,16q,17q25, 20p,3p26
• loci associated with psoriasis , two disease are rarely linked
genes expressed in skin play important role
• do not overlap with allelic variants that are frequent in allergic
asthma
Adv Immunol.2009;102;135-226
NJEM 2008;358:1483-94
8. Genetic of AD
• two major groups of genes
• (1) genes involved in skin barrier function : FLG, SCCE,
SPINK5
• (2) genes involved in the immune response
Adv Immunol.2009;102;135-226
9. Genes involved in skin barrier function
• strong genetic linkage to Chromosome 1q21 : human EDC
(epidermal differentiation complex )
• Mutations in the FLG (encode filaggrin) gene located on
chromosome 1q21.3
▫ identified in ichthyosis vulgaris, AD
Adv Immunol.2009;102;135-226
11. • 425 Singaporean Chinese patients
• All patients : Dx by two paediatric dermatologists according to the U.K.
Working Party’s diagnostic criteria for AD
• examined for palmar hyperlinearity and keratosis pilaris
• AD severity was graded as mild, moderate or severe according to SCORAD
• mean SD age was 10 5.18 years (range 1–21)
• 68% of patients were male
• Control : Genomic DNA from 440 Singaporean Chinese individuals was
obtained from the Singapore Bio Bank
• Unknown IV ⁄AD status
• mean SD age = 44 14 years (range 1–80), 44.1 males
Br J Dermatol2011;165:106–114
13. • Irish AD cohort is slightly enriched for cases of severe AD (47.8 defined by the Nottingham Eczema Severity
Score) compared with the Singaporean Chinese cohort (39.5 contributing factor
Br J Dermatol2011;165:106–114
14. • palmar hyperlinearity : PPV 34.1 , NPV 85.5
• keratosis pilaris : PPV 31.6%, NPV 79.3
• indicates that patients with AD with the absence of palmar
hyperlinearity and ⁄or keratosis pilaris are unlikely to carry FLG-null
mutations
Br J Dermatol2011;165:106–114
15. FLG
• Null mutations in the FLG gene are predisposing factor for
early-onset AD, which persists into adulthood
• FLG expression is also reduced in AD patients with no FLG
mutations
due to local expression of Th2 cytokines IL-4 ,IL-13 :
downregulate FLG expression in keratinocytes
Adv Immunol.2009;102;135-226
16. Genes involved in skin barrier function
SCCE (stratum corneum chymotryptic enzyme)
• 19q13
• play a central role in desquamation by cleaving proteins
of the SC
SPINK5 gene
• 5q32
• encodes LEKTI (lympho-epithelial kazal-type related
inhibitor) : regulates proteolysis in terminal keratinocyte
differentiation
• Mutations in SPINK5 : Netherton’s syndrome
▫ many features of AD including dermatitis, eosinophilia, and high IgE level
Adv Immunol.2009;102;135-226
17. Genes involved in skin barrier function
• E420K single nucleotide polymorphism (SNP) variant in the
SPINK5 gene
▫ significant association with disease severity
▫ presence of food allergy in children with AD
• Other protease inhibitors with similar roles to SPINK5 are
encoded by a cluster of genes on chromosome 20q12, :
linked to AD
Adv Immunol.2009;102;135-226
18. Genes involved in the immune response
Chromosome 5q31-33
• cytokine genes cluster
• Th2 : IL-4, IL-5, and IL-13
• CD14 antigen
• IL-12b subunit (IL-12 p40) (Th1 cytokines)
Chromosome 16q12
• SNPs within the a chain of the IL-4 receptor gene
Adv Immunol.2009;102;135-226
J Allergy Clin Immunol 2006;118:24-34
19. Genes involved in the immune response
Chromosome 11q22.2–22.3
• IL-18
Chromosome 1q31–32
• IL-10 gene , anti-inflammatory responses
Chromosome 11q13
• FcƐRI gene
• associate with AD and asthma
Chromosome 12q24
• IL-31, associated with itching
Adv Immunol.2009;102;135-226
20. Genes involved in the immune response
• Promoter region of lymphocyte- attracting chemokine
(17q)1
▫ RANTES (17q11) (regulated on activation, normal T-cell expressed and secreted)
▫ Eotaxin 1 (17q21.1-q21.2)
• Gain-of-function polymorphisms in the α subunit of IL-4
receptor (16q12) 2
• Polymorphisms of the gene encoding IL-18 (11q22) 2
1 J Allergy Clin Immunol 2006;118:24-34
2 NJEM 2008;358:1483-94
22. Barrier function of the skin
• Physical barrier
• Innate immune system
NJEM 2008;358:1483-94
23. Barrier function of the skin
• Cornified envelop (CE) :several proteins
▫ filaggrin, loricrin, trichohyalin, small
proline-rich proteins, involucrin and
keratin intermediate filaments
▫ cross-linked extensively by
transglutaminases
▫ epidermal differentiation complex
(EDC)
▫ a cluster of genes on human
chromosome 1q21
• SC lipid composition :
▫ ceramides (45–50% by weight)
▫ Cholesterol (25%)
▫ free fatty acids (10–15%)
▫ less than 5% each of several other
lipids : most important =
cholesterol sulfate
J Clin Invest.2006;116:1150-58
Adv Immunol.2009;102;135-226
24. • Profilaggrin : giant inactive precursor, highly phosphorylated polypeptide
• main constituent of keratohyalin F granules : granular cell layer
• profilaggrin is dephosphorylated and proteolytically cleaved by serine proteases, into
multiple filaggrin polypeptides
• filaggrin binds to keratin in a structure aligned parallel to the outer surface of the
epidermis
Adv Immunol.2009;102;135-226
26. Filaggrin
• filaggrin peptides are further degraded into hydrophilic amino
acids, including urocanic acid, pyrrolidone carboxylic acid,
and alanine 1
• Trans-urocanic acid : protection against ultraviolet
radiation,modulates immune function 2
• Pyrrolidone carboxylic acid :derivative of glutamine 2
• Arginine residues in filaggrin are converted to citrulline
proteolysis short peptides a pool of hygroscopic amino
acids and derivatives : natural moisturizing factor (NMF) 2
▫ involves caspase 14 and other proteases
1 Adv Immunol.2009;102;135-226
2 N Engl J Med 2011;365:1315-27.
27. Profilaggrin
• histidine-rich and glutamine-rich proteins
• modulate pH of the stratum corneum
• promote the retention of moisture
• possibly exert antimicrobial activity against
staphylococcus
N Engl J Med 2011;365:1315-27.
29. Physical barrier
proteases, and protease inhibitors
• Balance
• Proteases, especially SC tryptic and chymotryptic enzymes :
desmosome breakdown and corneocyte desquamation
• skin proteases is controlled by protease inhibitors
▫ SPINK5, a gene which encodes a putative serine protease
inhibitor, lymphoepithelial Kazal-type-related inhibitor (LEKTI)
Adv Immunol.2009;102;135-226
30. Physical barrier
• Changes in pH
• Changes in the cornified envelope proteins involucrin and
loricrin or lipid composition
• Decrease in ceramide
• Underlying inflammation can alter the expression of genes
such as FLG
increase in skin penetration of allergen and increased
TEWL
+ pruritus
inflammation and sensitization
NJEM 2008;358:1483-94
31. Innate immune system
• protect skin against infection
▫ Pathogen associated molecular pattern (PAMP)
molecules VS Pattern recognition receptors (PRRs)
▫ Antimicrobial peptides (AMPs)
Adv Immunol.2009;102;135-226
32. PAMPs and PRRs
• Toll-like receptors (TLRs) (TLR1-11)
• 39 C-type lectins
• nucleotide-binding oligomerization domain–like receptors
• peptidoglycan-recognition proteins (PGRPs) (4)
• expressed on macrophages, DCs, PMNs, mucosal epithelial,
and endothelial cells
NJEM 2008;358:1483-94
Adv Immunol.2009;102;135-226
33. Antimicrobial peptides (AMPs)
• expressed by keratinocytes and cells that form
sebaceous and sweat glands, mast cells, circulating
cells (PMNs,NK)
• Antimicrobial action against bacteria, viruses, and fungi
• 2 major classes
▫ cathelicidins
▫ defensins
Adv Immunol.2009;102;135-226
34. Innate immune system
• TH2 cytokine (prominent in AD) : IL-4, IL-13 down-regulates
antimicrobial peptides in skin difficult to manage
microbial infections
• Lesional and normal looking skin is extensively
colonized by bacteria such as Staphylococcus aureus or
fungi such as malassezia
• predisposed to eczema herpeticum and eczema
vaccinatum
(decrease cathelicidin potent antiviral activity)
NJEM 2008;358:1483-94
35. Immunopathologic mechanisms
• Early-onset atopic dermatitis : absence of IgE-mediated
allergic sensitization
• IgE mediated sensitization often occurs several weeks or
months after the lesions appear
▫ some children (mostly girls) —no IgE-mediated
allergic sensitization
• The initial mechanisms that induce skin inflammation in
patients with atopic dermatitis are unknown
NJEM 2008;358:1483-94
38. Key cell in AD
• T lymphocytes
• Dendritic cells (DCs)
• Keratinocytes
• Mast cells
• Eosinophils
J Allergy Clin Immunol
-
39. T lymphocyte
• LCs and DCs present antigen to recirculating naive T cells
• proliferation and differentiation into memory/effector cells that express skin
homing receptors such as
▫ cutaneous lymphocyte antigen (CLA)
▫ CCR4, and CCR10
• Antigen-specific effector CD4 T cells leave LN into the circulation and re-enter
the skin, via their skin specific receptors proliferate and secrete cytokine
Adv Immunol.2009;102;135-226
40. T lymphocyte
• Skin homing cutaneous lymphocyte antigen (CLA +) T cell
▫ CLA : inducible carbohydrate modification of P-selectin
glycoprotein ligand-1, memory T cells (absent on naïve)
▫ facilitates binding of T cells to E-selectin
▫ distinct capacity to home to the skin through expression of
the skin-homing receptor CLA 90% of infiltrating T cells
▫ IL-4 and IL-13 like TH2
▫ produce IL-31 Pruritus
J Allergy Clin Immunol 2006;117:418-25
42. • Cytokines :
▫ TNF-a and IL-1
▫ keratinocytes, mast cells, and DCs
▫ expression of vascular endothelial cell adhesion
molecules esp. VCAM-1, E-selectin, CD54
• Chemokines :
▫ Keratinocyte, LC
▫ RANTES, MCP-4, eotaxin : Eo, TH2 type lymphocyte
▫ IL-16 : CD4+ T cell
▫ CTACK/CCL27 : CTA+ T cell
▫ CCL1, CCL18
• extravasation of inflammatory cells
J Allergy Clin Immunol
Mark Boguniewicz, Donald Leung.Middleton’s Allergy 7’th edition 083-1099
-
43. Predominant TH2 profile
• TLSP : keratinocyte , LC
• TH1 cells : high IFN-ɣ–producing increased apoptosis
both TH1 and TH2 (TH1 > TH2 cells)
• Increased expression of Fas, Fas-ligand, tumor necrosis
factor receptor-II, and caspase activation was detected
on TH1 cells
• IFN-ɣ keratinocyte apoptosis
J Allergy Clin Immunol
44. T lymphocyte
• more chronic : expression of IFN-ɣ, IL-12, GM-CSF
• The mechanism : switch from Th2 to Th1 type
▫ is not well understood
▫ IDEC (Inflammatory dendritic epidermal cells) : IL12,18
▫ could be related to microbial products TLR2 is important
for Th1 response to cutaneously introduced antigen
Adv Immunol.2009;102;135-226
45. T lymphocyte : T reg
T regulatory (CD4+CD25+FOXP3)
• Immunosuppressive function
• Inhibit development of both TH1 and TH2 responses
• Increased in peripheral blood with normal immunosuppressive
activity
• decreased in lesion
J Allergy Clin Immunol 2006;117:418-25
• Staphylococcal superantigens subvert Treg cell function
▫ > 90% of patients have S. aureus colonization
▫ enhanced effector T cell activation skin inflammation
Adv Immunol.2009;102;135-226
46. IL-31
• cutaneous and peripheral blood CLA+ T cells : source
• correlation between IL-31 serum levels with the severity of AD
• staphylococcal enterotoxin rapidly induces IL-31 expression
in lymphocytes,monocytes and macrophages (but not on
dendritic) infection lead to exacerbation of pruritus
• IL-31 induces expression of the inflammatory T cell attracting
chemokines CCL17/TARC and CCL22/MDC (keratinocytes)
• IL-31 enhanced secretion of IL-1, IL-6 and IL-18 and up-
regulated CD86 expression
Adv Immunol.2009;102;135-226
Allergy 2010; 65: 712–721
47. T lymphocyte : Th17 cell
• markedly in acute than chronic AD lesions
• number of Th17 cells is increased in the peripheral blood of AD
• IL-17 serum levels are elevated
• IL-17 stimulates keratinocytes to produce GM-CSF, TNF-a, IL-
8, CXCL10, and vascular endothelial growth factor (VEGF),
and HBD-2
• produce IL-22
• marked synergistic effect between IL-17 and IL-22 was
observed on IL-8 and AMP production
Adv Immunol.2009;102;135-226
48. Dendritic Cells
• 2 myeloid dendritic cells (high-density display of FcεRI)
▫ Langerhans’ cells : normal skin
▫ Inflammatory dendritic epidermal cells(IDEC) : only in
inflamed skin
• Epidermal dendritic cells bear IgE and express its high-affinity
receptor(FcεRI)
• In skin lesions, dendritic cells of the plasmacytoid lineage
(potent antiviral activity IFN-α production) are almost absent
viral infection
Adv Immunol.2009;102;135-226
NJEM 2008;358:1483-94
49. Keratinocyte
• cutaneous immune responses
• production of proinflammatory cytokines, chemokines, AMPs
activation and recruitment of DCs, T cells, other leukocyte
amplify and maintain skin inflammation
• Itch induced scratching :release of proinflammatory cytokines and
chemokines
• Atopic keratinocyte-derived GM-CSF : proliferation and
differentiation of peripheral blood monocytes into mature DCs in
presence of IL-4
Adv Immunol.2009;102;135-226
50. Keratinocyte
• IL-1 and IL-18
▫ inactive precursors in keratinocytes
▫ converted to active forms by CASP1 enzyme after
stimulation by danger signals
▫ amount of active IL-18 in serum increases with
exacerbation of their disease
• TSLP
▫ Microbial products, physical injury, or inflammatory
cytokines, including proinflammatory (TNF-α and
J Allergy Clin Immunol
IL-1α) and Th2 (IL-4 or IL-13) cytokines induce -
TSLP
▫ polarizes human DCs to skew the T cell response
to Th2 Adv Immunol.2009;102;135-226
51. Keratinocyte
• activated skin-infiltrating T cell can upregulate Fas
expression on keratinocytes keratinocyte apoptosis
spongiosis (key pathogenic event in AD)
• overexpress numerous chemokines activation and
recruitment
▫ CCL20/MIP-3α, CCL27, CCL17/TARC, CCL22/MDC
- attract DCs and T cells
▫ CCL20/MIP-3α - recruitment of CCR6-expressing
immature DCs and memory/effector T
Adv Immunol.2009;102;135-226
52. Keratinocyte
• Keratinocyte-derived AMPs (antimicrobial peptide) : innate
▫ β-defensins (HBD-2 and HBD-3), and cathelicidin, hCAP18/ LL-
37
• Expression of HBD-2, HBD-3, and hCAP18/LL-37 is significantly
decreased in acute and chronic AD skin lesions compared to
psoriasis skin lesions
• IL-13 and IL-4 inhibit production of HBD-3 by keratinocytes
• Th2 cytokine may suppress innate immune response against
bacterial and viral pathogens
• Decreased AMPs in AD skin may contribute to its susceptibility to
infections
Adv Immunol.2009;102;135-226
53. Mast cell
• early stage AD : normal numbers but undergo degranulation in the
affected skin
• late stage AD : increased number, but without degranulation
• Mast cell-derived histamine, mast cell proteinases enzymes tryptase
and chymase (MCC), and other inflammatory mediators pruritus
and inflammation
• Histamine upregulates production
• inflammatory cytokines by keratinocytes
• Increased proteinase activity skin barrier defect
Adv Immunol.2009;102;135-226
54. Eosinophil
• common findings in AD
▫ Peripheral blood eosinophilia
▫ elevated serum levels of eosinophil granule proteins,
basic proteins eosinophil cationic protein (ECP),
eosinophil-derived neurotoxin (EDN)
major basic protein (MBP)
• correlate with disease activity
• increased expression : eosinophil chemotactic factor
CCL11/eotaxin and of IL-5 and IL-5Rα in acute and chronic skin
lesions , blood in AD patients
J Allergy Clin Immunol
-
Adv Immunol.2009;102;135-226
55. Eosinophil
• Eosinophils are recruited and activated by
IL-5 and IL-13
inflammation and tissue damage
• Inhibition of eosinophil apoptosis in AD : IL-5
,GM-CSF
• Eosinophils : switching TH1 response by IL-
12
• more pronounced in chronic AD
J Allergy Clin Immunol
-
Adv Immunol.2009;102;135-226
56. NK cell
• release of perforin and granzyme
• Release proinflammatory cytokines such as IFN-g, TNF-a,
GM-CSF, IL-5, and IL-8 recruitment of other innate immune
cells
• Circulating CD56+CD16+ NK cells are reduced but increases
in lesional skin with severity of disease
• NK : functionally defective in AD
▫ MHC-nonrestricted cytotoxicity against standard NK-
sensitive target cells
▫ reduced release of IFN-ɣ
• Decreased NK activity skin infection
Adv Immunol.2009;102;135-226
57. PMNs
• lack of detectable PMNs in skin lesion
• PMN chemotactic defect
▫ found to correlate with markers of AD disease severity, serum IgE levels,
and skin bacterial infection
• PMN functions are impaired especially during infectious period
▫ impaired phagocytosis, reduced capacity to produce reactive oxygen
species, impaired release of β-glucuronidase, defective leukotriene B4
production and release
▫ absent deposition of extracellular PMN granule proteins (lactoferrin and
PMN elastase)
• contribute to the susceptibility of AD skin to infection
Adv Immunol.2009;102;135-226
59. Autoimmunity in Atopic Dermatitis
• In addition to IgE antibodies against food and aeroallergens
• Serum from patients with severe atopic dermatitis contain IgE
antibodies against proteins from keratinocytes and endothelial
cells
▫ manganese superoxide dismutase
▫ calcium-binding proteins
• serum levels of these IgE autoantibodies correlate with
disease severity
• Scratching probably releases intracellular proteins from
keratinocytes
• These proteins could be molecular mimics of microbial
structures induce IgE autoantibodies
NJEM 2008;358:1483-94
60. Autoimmunity in Atopic Dermatitis
• 25% of adults AD : IgE antibodies against self-proteins
• these patients, early-onset atopic dermatitis, intense pruritus,
recurrent bacterial skin infections, and high serum IgE levels are
hallmarks of disease
• IgE antibodies against self-proteins can be detected in patients with
atopic dermatitis as early as 1 year of age
• IgE antibodies against autoantigens in skin can perpetuate the
allergic inflammation
NJEM 2008;358:1483-94